A Study to Evaluate the Effect of Letrozole and Tamoxifen on Bone and Lipids in Postmenopausal Women With Breast Cancer

NCT00171704 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

263

Enrollment

INDUSTRY

Sponsor class

Conditions

Hormone Sensitive Resected Primary Breast Cancer in Postmenopausal Women

Interventions

DRUG: Letrozole
DRUG: Tamoxifen

Sponsor

Novartis Pharmaceuticals

Collaborators

[object Object]
[object Object]